A previous study demonstrated functional synergy of PD-1 and Lag3 in the control of anti-tumour immunity [46], and this was linked to increases in IFN-gamma-expressing cells amongst both CD4+ and CD8+ T cells [46]. The gene discussed is IFNG; the disease is neoplasm.